MD, PhD

Dr. Krishnan Chakravarthy, MD, PhD, is an anesthesiologist who specializes in multi-modal pain management. He completed fellowship training in pain management at Harvard Medical School, Massachusetts General Hospital and residency training in anesthesiology at Johns Hopkins School of Medicine, The Johns Hopkins Hospital. Dr. Chakravarthy earned his medical and doctorate degree from the University at Buffalo School of Medicine and Biomedical Sciences and spent a portion of his doctoral work at the United States Centers for Disease Control. As an Assistant Professor in the Department of Anesthesiology, and Affiliate Professor in the Department of Nanoengineering, Dr. Chakravarthy instructs medical students, residents and fellows at UC San Diego School of Medicine and San Diego VA hospital. In addition, he runs his own National Institute of Health funded laboratory that is involved in cutting edge translational research and clinical trials focusing on new medical devices and drug therapies for chronic pain management. His research interests include incorporating new technology into advancing pain care. This includes advancing the field of neuromodulation, novel small molecule drug development, and novel medical device development. His research work has been featured in national and international venues and has been published in top journals, including Anesthesiology, Proceedings of the National Academy of Sciences of the United States of America, and Pain.

Dr. Chakravarthy has published extensively and currently serves on the editorial board of several national and international peer reviewed journals, and committees on organizations such as the International Neuromodulation Society, and American Society of Pain and Neuroscience. He is the recipient of several national clinical and research awards including the inaugural young innovator award from the American Society of Pain and Neuroscience.

An entrepreneur, Dr. Chakravarthy is a founder of several biotechnology startup companies focusing on applications of nanotechnology in the pain space, small molecule drug development, and the field of neuromodulation. He is a consultant and on the medical advisory board of some of the largest medical device companies worldwide to help advance new products centered around patient care.